In MASLD, aberrant activation of YAP/TAZ is intricately linked to hepatocyte stress, steatosis, inflammation, and fibrosis, representing a critical nexus throughout disease progression. The gene discussed is YAP1; the disease is metabolic dysfunction-associated steatotic liver disease.